Updated interim data from an ongoing Phase I dose-escalation phase clinical study (NCT03748186) evaluating the folate receptor alpha (FRα) antibody-drug conjugate (ADC) STRO-002 (Sutro Biopharma) shows encouraging results.[1] The trial was designed to study the safety and anti-tumor activity results in heavily pre-treated patients with ovarian cancer. Folate receptor alpha or FRα is a glycosylphosphatidylinositol (GPI)-anchored membrane protein is overexpressed in solid […]

NEW YORK, April 23, 2020 /PRNewswire/ — Russo Partners’ Sports-Health Alliance, part of the New York City-based healthcare and technology communications firm, has launched “Stay Safe. Stay Together. Stay Healthy,” a social media campaign to encourage individuals to reconnect, rebuild and strengthen personal relationships despite the stay-at-home orders in place because of the COVID-19 pandemic. Today’s national kick-off includes […]

LONDON – The search for modulators of the immune cascade that is the cause of the most severe respiratory symptoms of COVID-19 is intensifying, with Cyclacel Pharmaceuticals Inc. and Pharming Group NV adding their drugs to the list of repurposing projects. Leiden, Netherlands-based Pharming is planning a 150-patient trial of its C1 inhibitor Ruconest after seeing encouraging results in a compassionate […]